Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Mary Farrant(University of California, San Francisco), S. Claiborne Johnston(University of California, San Francisco), Jordan Elm(Medical University of South Carolina), Wenle Zhao(Medical University of South Carolina), J. Donald Easton(University of California, San Francisco), Joan Martí‐Fábregas(Hospital General Universitario de Albacete), Brett Cucchiara, Keith Pauls(Medical University of South Carolina), Eric E. Adelman(University of Wisconsin–Madison), Anne S. Lindblad, Richard A. Bernstein(Northwestern University), Holly Tillman(Medical University of South Carolina), William G. Barsan, Kyle Walsh(University of Cincinnati)
Cited by 13
Related Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
|Stroke|2014|5.2k
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Cryptogenic Stroke and Underlying Atrial Fibrillation
|New England Journal of Medicine|2014|2.2k